Home > Boards > US Listed > Biotechs > 22nd Century Group (XXII)

10/21/20 - 11:15 a.m. ET. (FDA Update)

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Canna_Business Member Profile
 
Followed By 6
Posts 1,058
Boards Moderated 2
Alias Born 12/03/16
160x600 placeholder
22nd Century Group to Present at 13th Annual LD Micro Main Event Conference GlobeNewswire Inc. - 12/4/2020 10:00:00 AM
22nd Century’s Vice President of Regulatory Science Publishes Important Public Policy Article GlobeNewswire Inc. - 11/24/2020 11:00:00 AM
22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference GlobeNewswire Inc. - 11/18/2020 10:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/17/2020 2:32:43 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 11/16/2020 12:03:08 PM
22nd Century Group to Present at the Virtual Fall Investor Summit on November 17 GlobeNewswire Inc. - 11/16/2020 9:45:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2020 7:24:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 7:16:55 AM
22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020 GlobeNewswire Inc. - 11/5/2020 7:00:00 AM
22nd Century Group to Host Third Quarter 2020 Webcast and Conduct Quarterly Q&A GlobeNewswire Inc. - 10/22/2020 10:00:10 AM
22nd Century Group to Highlight its Reduced Nicotine Technology at The Food and Drug Law Institute’s Tobacco and Nicotine P... GlobeNewswire Inc. - 10/19/2020 10:00:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 10/14/2020 3:44:51 PM
22nd Century Group Achieves Breakthrough Technology; Granted New Patent for Reducing Nicotine in Tobacco Plants GlobeNewswire Inc. - 10/14/2020 1:00:10 PM
22nd Century Group Provides Strategy Update Letter from CEO GlobeNewswire Inc. - 9/24/2020 4:05:10 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/22/2020 3:14:04 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2020 4:17:13 PM
22nd Century Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors GlobeNewswire Inc. - 9/17/2020 4:05:10 PM
22nd Century Group to Present at the LD Micro 500 Virtual Conference GlobeNewswire Inc. - 8/27/2020 11:30:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 8/6/2020 1:14:22 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2020 7:31:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2020 7:01:16 AM
22nd Century Group Reports Financial Results and Business Highlights for the Second Quarter 2020 GlobeNewswire Inc. - 8/6/2020 7:00:10 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/31/2020 7:41:24 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 7/21/2020 3:46:37 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/10/2020 10:40:44 AM
Canna_Business   Monday, 10/19/20 11:42:35 AM
Re: None
Post # of 51682 
10/21/20 - 11:15 a.m. ET. (FDA Update)

“I am delighted to participate in this important conference and to support, with our reduced nicotine technology, FDA’s plan to implement a reduced nicotine product standard."

“The science is clear. By limiting the nicotine content of all combustible cigarettes to levels achieved in our VLN® cigarettes, the FDA projects that five million adult smokers would quit one year after implementation and over eight million American lives would be saved by the end of the century. Our goal for this conference, as in general, is to advance common-sense tobacco and nicotine regulation and unite against the tragic toll of cigarette addiction to improve public health in America.”

"Mitchell R. Zeller, director of the Center for Tobacco Products (CTP) at the U.S. Food and Drug Administration (FDA), will provide an update on the FDA’s Comprehensive Plan for Tobacco and Nicotine Products at the Food and Drug Law Institute’s (FDLI) Tobacco and Nicotine Products Regulation and Policy Conference on Wednesday October 21, 2020 at 11:15 a.m. ET."

"22nd Century believes that the FDA is in the final stages of its decision-making process for the Company’s Modified Risk Tobacco Product (MRTP) Applications for VLN®."

Article:
https://www.xxiicentury.com/news-media/press-releases/detail/401/22nd-century-group-to-highlight-its-reduced-nicotine

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences